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Abstracts of the 7th International Congress of the Asia Pacific Society of Infection Control, Taipei, Taiwan, March 26-29, 2015 S7Standards includes Standard 3 “Preventing and Controlling Healthcare
Associated Infections”. The intent of Standard is to:
“Prevent patients from acquiring preventable healthcare associated infec-
tions and effectively manage infections when they occur by using evi-
dence-based strategies”.
The NSQHS Standards are being implemented in all public and private
hospitals and day procedure centres in Australia.KS 15
INFECTION CONTROL 2025
Andreas Voss. CWZ & RUMC, Nijmegen, The NetherlandsIn the talk the personal opinion of the
speaker with ragd to infection control and
its development over the next 10 years. The
talk will be centered around 6 main topics:
ʘ Basics are the new black
ʘ MDRO e are they all equal?
ʘ Regional efforts
ʘ Perceptions (Infection Control vs
Clinicians)
ʘ Less is more! (Guidelines)
ʘ Help e by design and by patientsThe content of the 6 basic principles on which Infection Control should focus
will be further explained. In addition other factors might be mentioned, such
as: infection control indicators, public reporting (2nd gen surveillance),
integration of MMB/ID/AMS/IC at regional levels, remote video assisted
behavior change (audits), nanotechnology for surfaces, virtual reality/
serious gaming. for HCWs training, robots/avatars for patients assist
KS 16
THE MANAGEMENT AND A NEW STRATEGY AGAINST CARBAPENEM-
RESISTANT ENTEROBACTERIACEAE INFECTION
Kazuhiro Tateda, MD, PhD. Department of Microbiology and Infectious
Diseases, Toho University School of Medicine, Tokyo 143-8540, JapanAppearance and spreading of antibiotic
resistant organisms are everywhere in the
world. In Japan, we have still problems of
MRSA in the hospital and also recent epide-
miological data demonstrated increase of
community-associated MRSA not only in
healthy individuals but hospital-admitted
patients. Not many, but we experienced
several outbreaks of multiple drug resitant
Pseudomonas aeruginosa and Acinetobacter
baumannii infections. Colistine is now a
topic of antibacterial to treat MDR organ-isms, which was created in Japan for the first time on 1950’. In historical
perspective, Japanese pharmaceutical companies have created interna-
tionally well accepted and widely used antibiotics, like cephazoline, levo-
floxacin, clarithromycin, tazobactam/piperacillin and meropenem. But
unfortunately, we are facing to a difficulty to produce newer generation
of antibacterials, even from those companies that produced golden stan-
dard compounds. In this talk, I would like to review several pipelines of
antibiotics which were evaluated in vitro, in vivo animal model and clin-
ical trial in some compounds. Some of them were reviewed in ICAAC
2014 in US, as promising agents in poster summary session. In addition, I
would like to show some experimental data of antibiotic therapeutic stra-
tegies, such as rationale of combination treatment (Break-point checker-
board plate) and inhibitors of metallo-beta-lactamase by zinc-chelating
agents.KS 17
CONTROLLING MULTI-DRUG RESISTANCE
Ian M. Gould. Royal Infirmary, Aberdeen, United KingdomThe question posed by the title is one of the critical
issues for health care at present, and surely for all
time unless some new ways to control bacteria can
be developed.
Resistance would not be an issue were it not for the
widespread use of antibiotics so, in the absence of
significant new antibiotic development, our efforts
must concentrate on reducing selection of resistance
and preventing its transmission.
Most experience, and success, has been gained
through our efforts to control hospital MRSA, and I
will discuss recent experience in the UK, USA andEurope to illustrate several basic principles that might be applied to the
control of most multi-resistant organisms.
For many years hospitals tried to control MRSA with “horizontal”
measures, that is generic precautions (often known as standard pre-
cautions) such as hand washing that it was envisaged would stop spread
of many pathogens. Clearly these failed to control MRSA, and as we
learnt more about its epidemiology, we were able to design specific
(vertical) precautions that specifically targeted the selection and spread
of MRSA.
Implementation of such measures in the UK in particular, has been
spectacularly successful in controlling MRSA. Universal admission screening
for MRSA, patient isolation and decolonization and the avoidance of key
antibiotics eg cephalosporins and quinolones have been particularly effec-
tive. Adjunctive measures such as improved hand hygiene and environ-
mental decontamination can also play a role.
The application of the same general principles to control of other MDR
organisms will likely be effective, if they are targeted to particular aspects
of the epidemiology of each organism.
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HAND HYGIENE PROMOTION AND THE PARTICIPATION OF INFECTION
CONTROL LINK NURSES: AN EFFECTIVE INNOVATION TO OVERCOME
CAMPAIGN FATIGUE
Patricia Ching, Principal Nurse. WHO Collaborating Centre on Infectious
Disease Epidemiology and Control, The University of Hong Kong, Hong Kong
Special Administrative RegionThe WHO has introduced a multimodal meth-
odology for the implementation of the hand
hygiene program. After a few years of promo-
tion and implementation, a common problem is
campaign fatigue when there is evidence that
promotional activities are being ignored and
hand hygiene compliance plateau at just 50%.
Three methods are often used to overcome this
including keep on expanding the campaign,
effective linkage to other healthcare programs,
and regular reinforcement.
An examples will be presented from the HongKong experience. (Seto et al AJIC 2013 (41):12: 128). Hand hygiene was
introduced in the 850-bed Hong Kong Baptist Hospital (HKBH) showing signif-
icant improvement in compliance in 2008 from 41% to 58% (p<0.01). Subse-
quently from 2008 to 2011, it persists below the 55% level in spite of active
promotional activities, indicating campaign fatigue. HKBH has 99 infection
control link nurses (ICLNs) and using focus groups, four key deficiencies
were identified and for each, a program was implemented to resolve
them. The four programs are as follows:
1. Help your doctor for excellence in Hand Hygiene: To reverse the low
compliance among doctors, accompanying nurses squirt alcohol for them
during ward rounds.
2. Competition for “Speaking Walls” posters: ICLNs help each ward to pro-
duce self-made posters because the present reminders were deemed inef-
fective. It is believed that self-designed posters will be better reminders.
